CYPRESS SEMICONDUCTOR CORPORATION | ||||||||||||||||||||
CONSOLIDATED DILUTED EPS CALCULATION | ||||||||||||||||||||
(In thousands, except per-share data) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended | ||||||||||||||||
|
|
January 3, |
|
September 27, |
|
December 28, |
|
January 3, |
|
December 28, | ||||||||||
|
|
2016 |
|
2015 |
|
2014 |
|
2016 |
|
2014 | ||||||||||
|
|
GAAP |
|
Non-GAAP |
|
GAAP |
|
Non-GAAP |
|
GAAP |
|
Non-GAAP |
|
GAAP |
|
Non-GAAP |
|
GAAP |
|
Non-GAAP |
Net income (loss) attributable to Cypress |
|
$ (77,259) |
|
$ 45,528 |
|
$ 30,312 |
|
$ 60,040 |
|
$ 3,502 |
|
$ 22,055 |
|
$ (383,796) |
|
$ 70,532 |
|
$ 17,936 |
|
$ 87,291 |
Weighted-average common shares outstanding basic |
|
334,447 |
|
334,447 |
|
335,299 |
|
335,299 |
|
161,864 |
|
161,864 |
|
302,036 |
|
302,036 |
|
159,031 |
|
159,031 |
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options, unvested restricted stock and other |
|
— |
|
15,363 |
|
9,161 |
|
14,549 |
|
7,284 |
|
8,892 |
|
— |
|
21,223 |
|
10,091 |
|
9,331 |
Impact of convertible bond |
|
— |
|
12,419 |
|
13,197 |
|
13,197 |
|
— |
|
— |
|
— |
|
12,419 |
|
— |
|
— |
Weighted-average common shares
|
|
334,447 |
|
362,229 |
|
357,657 |
|
363,045 |
|
169,148 |
|
170,756 |
|
302,036 |
|
335,678 |
|
169,122 |
|
168,362 |
Net income (loss) per share attributable to Cypress - basic |
|
$ (0.23) |
|
$ 0.14 |
|
$ 0.09 |
|
$ 0.18 |
|
$ 0.02 |
|
$ 0.14 |
|
$ (1.27) |
|
$ 0.23 |
|
$ 0.11 |
|
$ 0.55 |
Net income (loss) per share attributable to Cypress - diluted |
|
$ (0.23) |
|
$ 0.13 |
|
$ 0.08 |
|
$ 0.17 |
|
$ 0.02 |
|
$ 0.13 |
|
$ (1.27) |
|
$ 0.21 |
|
$ 0.11 |
|
$ 0.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended |
|
|
|
|
|
|
|
|
|
| ||||||
|
|
January 3, |
|
September 27, |
|
December 28, |
|
January 3, |
|
December 28, |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
2015 |
|
2014 |
|
2016 |
|
2014 |
|
|
|
|
|
|
|
|
|
|
Average stock price for the period ended |
|
$ 9.87 |
|
$ 10.64 |
|
$ 10.77 |
|
$ 12.10 |
|
$ 10.18 |
|
|
|
|
|
|
|
|
|
|
Common stock outstanding at period end (in thousands) |
|
332,276 |
|
335,590 |
|
163,103 |
|
332,276 |
|
163,013 |
|
|
|
|
|
|
|
|
|
|
NOTES TO NON-GAAP FINANCIAL MEASURES